INVESTOR NEWS no. 18 – 11 June 2026 Ferry – freight: In May 2026, total volumes of 3.6m lane metres were 1.8% below 2025 and down 1.7% adjusted for route changes. North Sea volumes were above 2025 following higher volumes on most routes. Mediterranean volumes were overall below 2025, partly due to a higher number of Turkish public holidays in May 2026 compared to 2025. Volume growth on the Egypt and Tunisia routes continued. Channel volumes were below 2025 driven by lower volumes on the Dover Strait. Baltic Sea volumes were well above 2025 and Strait of Gibraltar volumes were also above 2025. For the last twelve months, the total transported freight lane metres increased 0.3% to 41.8m from 41.7m in 2025-24 and decreased 1.5% adjusted for route changes. Ferry – passenger: In May 2026, the number of passengers adjusted for...

ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada. Oculis is a proud sponsor of Clinical Trials at the Summit 2026, which brings together experts from around the world to discuss ongoing clinical trials and the latest data, all with the goal of achieving advances in vitreoretinal care. Details of Oculis’ presentation are as follows: Clinical Trials at the Summit 2026:Privosegtor in Optic Neuritis: From Discovery to PIONEER Registrational TrialsPresenter: Riad Sherif, M.D.,...

INVESTOR NEWS no. 18 – 11 June 2026 Ferry – freight: In May 2026, total volumes of 3.6m lane metres were 1.8% below 2025 and down 1.7% adjusted for route changes. North Sea volumes were above 2025 following higher volumes on most routes. Mediterranean volumes were overall below 2025, partly due to a higher number of Turkish public holidays in May 2026 compared to 2025. Volume growth on the Egypt and Tunisia routes continued. Channel volumes were below 2025 driven by lower volumes on the Dover Strait. Baltic Sea volumes were well above 2025 and Strait of Gibraltar volumes were also above 2025. For the last twelve months, the total transported freight lane metres increased 0.3% to 41.8m from 41.7m in 2025-24 and decreased 1.5% adjusted for route changes. Ferry – passenger: In May 2026, the number of passengers adjusted for...

ZUG, Switzerland, June 11, 2026 – Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada. Oculis is a proud sponsor of Clinical Trials at the Summit 2026, which brings together experts from around the world to discuss ongoing clinical trials and the latest data, all with the goal of achieving advances in vitreoretinal care. Details of Oculis’ presentation are as follows: Clinical Trials at the Summit 2026:Privosegtor in Optic Neuritis: From Discovery to PIONEER Registrational TrialsPresenter: Riad Sherif, M.D., Chief Executive OfficerDate/Time:...

PRESS RELEASE                                         Share Buyback Transaction Details June 4 – June 10, 2026 Alphen aan den Rijn – June 11, 2026 – Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 61,431 of its own ordinary shares in the period from June 4, 2026, up to and including June 10, 2026, for €3.9 million and at an average share price of €63.23. These repurchases are part of the share buyback program announced on February 25, 2026, under which we intend to repurchase shares for up to €500 million during 2026. The cumulative amounts repurchased in the year to date under this program are as follows: Share Buyback 2026Period Cumulative shares repurchased in period Total consideration(€ million) Average share price(€)2026...

Montrouge, June 11, 2026 Crédit Agricole Financement de l’Habitat SFH ANNOUNCES EARLY REPURCHASE OF EUR 3,250,000,000 “obligations de financement de l’habitat” Fixed Rate Notes issued on July 28, 2023 and due December 15, 2026 (ISIN: FR001400JM17)* Crédit Agricole Financement de l’Habitat SFH (the “Issuer”) announces today the early repurchase (the « Repurchase ») with effect on June 16, 2026 (the « Repurchase Date ») of all of its outstanding EUR 3,250,000,000 “obligations de financement de l’habitat” Fixed Rate Notes issued on July 28, 2023 and due December 15, 2026 (ISIN: FR001400JM17) (the « Notes ») pursuant to the Terms and Conditions of the Notes (the “Terms and Conditions”) included in the prospectus dated July 20, 2023, which was granted the visa n°23-326 by the Autorité des marchés financiers on July...

VANCOUVER, BRITISH COLUMBIA, June 11, 2026 (GLOBE NEWSWIRE) — HI-VIEW RESOURCES INC. (“Hi-View” or the “Company”) (CSE: GXLD; OTCQB: GXLDF; FSE: B630) announces the receipt of two complementary satellite alteration mapping reports for its Toodoggone Portfolio claims in British Columbia, both prepared by PhotoSat Information Inc. The ASTER Alteration Mapping Report and the EnMAP Regional Hyperspectral Exploration Targeting Report together provide an advanced multi-sensor characterization of hydrothermal alteration across the property and will directly inform ground-based exploration targeting for the upcoming field season. Nader Mostaghimi, Vice President Exploration commented: “These data acquisitions represent a valuable addition to our exploration toolkit, supporting our vectoring efforts toward epithermal and porphyry mineralization...

Over half (54%) of adults at risk of anaphylaxis admit they have been without their adrenaline auto-injector (AAI) when needed—and nearly 40% do not carry one regularly (n=1,238 ).1 HCP survey data suggests only around half of patients consistently carry their prescribed AAI, with adherence perceived to be lowest among adolescents.2 EURneffy®, the only needle-free nasal adrenaline spray, was strongly and consistently preferred over AAIs by patients across four countries in a discrete choice experiment.1 In a simulated-use study, participants said they would find EURneffy® significantly easier to use and would act earlier than with an AAI.3New scientific data reveal serious shortcomings in the real-world management of anaphylaxis, with findings from two multi-country surveys suggesting that EURneffy®—the first and only approved needle-free...

Nokia introduces agentic AI framework in Network Services Platform to enable trust-based AI operations for IP networksNokia NSP adds an agentic AI framework that lets operators deploy AI agents grounded in a real-time, accurate network view — enabling them to reason based on trusted data and take guided, explainable actions within operator-defined policies and security boundaries. Nokia AI-driven Troubleshooting Agent accelerates root-cause analysis, reduces operational noise, and turns complex IP issues into guided, explainable workflows. Framework supports communication with external agents via new AI-based protocols across operators’ multi-vendor, multi-domain networks, empowering them on their journey toward fully autonomous networks.11 June 2026  Espoo, Finland – Nokia today announced an enhancement to its Network Services Platform...